Our results showed that there were only 27 (56.2%) adenocarcinoma patients with high expression levels (++, intensity score: 5–7) of IL-33 in tumor tissues, while 43 (89.6%) adjacent normal tissues had high expression levels of IL-33 (Fig 2 and Table 3). The gene discussed is IL33; the disease is adenocarcinoma.